{"id":"W4229684386","doi":"10.1177/120347540500900607","title":"Safety of Efalizumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: Review of Clinical Data. Part II","year":2005,"lang":"en","type":"article","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Efalizumab; Medicine; Adverse effect; Placebo; Psoriasis; Clinical trial; Incidence (geometry); Internal medicine; Dermatology; Plaque psoriasis; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003306249,0.000877592,0.003320903,0.001975525,0.000224962,0.0009630531,0.000857537,0.0009572351,0.001568113],"category_scores_gemma":[0.004514029,0.0004611955,0.001522857,0.002382391,0.0005350199,0.000748926,0.0003430901,0.000778096,0.0005591846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006691384,"about_ca_system_score_gemma":0.001228753,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009235853,"about_ca_topic_score_gemma":0.001623522,"domain_scores_codex":[0.9988373,0.0004183824,0.0003376059,0.00009756869,0.0002734811,0.00003569475],"domain_scores_gemma":[0.9953713,0.002258461,0.001668464,0.00007444136,0.0005238136,0.0001034665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001870449,0.000120321,0.001136233,0.150592,0.00225508,0.0002182125,0.00009322511,0.0002702832,0.002487894,0.0003609342,0.01493739,0.825658],"study_design_scores_gemma":[0.003967261,0.01253064,0.05277425,0.1923613,0.02855721,0.01034245,0.0003985832,0.000795066,0.004170091,0.003067946,0.6908853,0.0001497668],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000372201,0.9990809,0.00007112494,0.0001626749,0.00007293248,0.00002948659,0.00002557011,0.000003212057,0.0001818456],"genre_scores_gemma":[0.005142448,0.9936492,0.000233802,0.0004795892,0.0002035096,0.00005694032,0.00006995369,0.000002554625,0.0001620737],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003320903,"threshold_uncertainty_score":0.01748538,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03849130579220388,"score_gpt":0.2978299855919772,"score_spread":0.2593386797997733,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}